| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.71e-09 | 37 | 31 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.11e-09 | 38 | 31 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 2.83e-07 | 9 | 31 | 3 | GO:0043878 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.71e-07 | 109 | 31 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 9.59e-07 | 49 | 31 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 1.52e-06 | 15 | 31 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 2.27e-06 | 17 | 31 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | activin receptor antagonist activity | 2.33e-06 | 2 | 31 | 2 | GO:0038102 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor activity | 2.33e-06 | 2 | 31 | 2 | GO:0008281 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 7.49e-06 | 178 | 31 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATP-activated inward rectifier potassium channel activity | 3.49e-05 | 6 | 31 | 2 | GO:0015272 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.17e-05 | 441 | 31 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 5.59e-05 | 48 | 31 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 7.98e-05 | 477 | 31 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 8.88e-05 | 56 | 31 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.04e-04 | 10 | 31 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.20e-04 | 62 | 31 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.50e-04 | 775 | 31 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | NAD binding | 1.96e-04 | 73 | 31 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 2.45e-04 | 839 | 31 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 2.47e-04 | 840 | 31 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 2.47e-04 | 840 | 31 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.15e-04 | 614 | 31 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | zinc ion binding | 3.53e-04 | 891 | 31 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | peptidase activity | 4.41e-04 | 654 | 31 | 6 | GO:0008233 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.84e-04 | 430 | 31 | 5 | GO:0004175 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 8.60e-04 | 28 | 31 | 2 | GO:0005242 | |
| GeneOntologyMolecularFunction | receptor antagonist activity | 1.12e-03 | 32 | 31 | 2 | GO:0048019 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 1.27e-03 | 34 | 31 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.67e-03 | 39 | 31 | 2 | GO:0015605 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.86e-03 | 1180 | 31 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.94e-03 | 1189 | 31 | 7 | GO:0046914 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.19e-03 | 891 | 31 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.31e-03 | 46 | 31 | 2 | GO:0016893 | |
| GeneOntologyMolecularFunction | signaling receptor inhibitor activity | 2.31e-03 | 46 | 31 | 2 | GO:0030547 | |
| GeneOntologyMolecularFunction | transporter activity | 3.07e-03 | 1289 | 31 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 4.03e-03 | 61 | 31 | 2 | GO:1901682 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 7.34e-03 | 83 | 31 | 2 | GO:0015101 | |
| GeneOntologyMolecularFunction | syntaxin binding | 8.04e-03 | 87 | 31 | 2 | GO:0019905 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.04e-02 | 293 | 31 | 3 | GO:0008514 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.09e-02 | 102 | 31 | 2 | GO:0043178 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.09e-02 | 102 | 31 | 2 | GO:0005249 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.12e-02 | 301 | 31 | 3 | GO:0022853 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 1.63e-02 | 1353 | 31 | 6 | GO:0004888 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.68e-02 | 128 | 31 | 2 | GO:0005267 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.86e-05 | 106 | 31 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | cellular detoxification of aldehyde | 9.76e-05 | 10 | 31 | 2 | GO:0110095 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 2.93e-04 | 17 | 31 | 2 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 3.29e-04 | 18 | 31 | 2 | GO:0006067 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 3.34e-04 | 641 | 31 | 6 | GO:1901615 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 3.41e-04 | 91 | 31 | 3 | GO:0140115 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 3.44e-04 | 412 | 31 | 5 | GO:0006066 | |
| GeneOntologyBiologicalProcess | cellular response to aldehyde | 4.08e-04 | 20 | 31 | 2 | GO:0110096 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 4.51e-04 | 21 | 31 | 2 | GO:0032926 | |
| GeneOntologyBiologicalProcess | regulation of dopamine metabolic process | 5.42e-04 | 23 | 31 | 2 | GO:0042053 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 5.42e-04 | 23 | 31 | 2 | GO:0034310 | |
| GeneOntologyBiologicalProcess | vitamin transmembrane transport | 5.42e-04 | 23 | 31 | 2 | GO:0035461 | |
| GeneOntologyBiologicalProcess | viral process | 5.91e-04 | 464 | 31 | 5 | GO:0016032 | |
| GeneOntologyBiologicalProcess | transition metal ion transport | 6.44e-04 | 113 | 31 | 3 | GO:0000041 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine metabolic process | 6.95e-04 | 26 | 31 | 2 | GO:0042069 | |
| GeneOntologyCellularComponent | potassium ion-transporting ATPase complex | 5.97e-06 | 3 | 30 | 2 | GO:0031004 | |
| GeneOntologyCellularComponent | inward rectifying potassium channel | 1.19e-05 | 4 | 30 | 2 | GO:0008282 | |
| Domain | ABC_transporter_CS | 3.19e-07 | 42 | 26 | 4 | IPR017871 | |
| Domain | ABC_TRANSPORTER_2 | 5.51e-07 | 48 | 26 | 4 | PS50893 | |
| Domain | ABC_tran | 5.51e-07 | 48 | 26 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 5.99e-07 | 49 | 26 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 6.50e-07 | 50 | 26 | 4 | IPR003439 | |
| Domain | Ald_DH_CS_GLU | 1.33e-06 | 16 | 26 | 3 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 1.61e-06 | 17 | 26 | 3 | IPR016160 | |
| Domain | Sulphorea_rcpt | 1.86e-06 | 2 | 26 | 2 | IPR000388 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 1.93e-06 | 18 | 26 | 3 | PS00687 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 1.93e-06 | 18 | 26 | 3 | PS00070 | |
| Domain | - | 2.29e-06 | 19 | 26 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 2.29e-06 | 19 | 26 | 3 | PF00171 | |
| Domain | Aldehyde_DH_dom | 2.29e-06 | 19 | 26 | 3 | IPR015590 | |
| Domain | - | 2.29e-06 | 19 | 26 | 3 | 3.40.309.10 | |
| Domain | Ald_DH_C | 2.29e-06 | 19 | 26 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 2.29e-06 | 19 | 26 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 2.29e-06 | 19 | 26 | 3 | IPR016161 | |
| Domain | ABC_membrane | 4.75e-06 | 24 | 26 | 3 | PF00664 | |
| Domain | ABC_TM1F | 7.67e-06 | 28 | 26 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 7.67e-06 | 28 | 26 | 3 | IPR011527 | |
| Domain | AAA+_ATPase | 4.44e-05 | 144 | 26 | 4 | IPR003593 | |
| Domain | AAA | 4.44e-05 | 144 | 26 | 4 | SM00382 | |
| Domain | - | 4.62e-04 | 746 | 26 | 6 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 9.07e-04 | 848 | 26 | 6 | IPR027417 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.09e-07 | 44 | 19 | 4 | M11911 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 3.40e-07 | 11 | 19 | 3 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 4.53e-07 | 12 | 19 | 3 | M14663 | |
| Pathway | KEGG_LIMONENE_AND_PINENE_DEGRADATION | 7.70e-05 | 10 | 19 | 2 | M17395 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 7.70e-05 | 10 | 19 | 2 | MM15833 | |
| Pathway | REACTOME_ABC_TRANSPORTER_DISORDERS | 1.48e-04 | 78 | 19 | 3 | M27473 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 1.79e-04 | 15 | 19 | 2 | M39717 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.47e-04 | 104 | 19 | 3 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.57e-04 | 105 | 19 | 3 | MM14842 | |
| Pathway | KEGG_BETA_ALANINE_METABOLISM | 3.91e-04 | 22 | 19 | 2 | M2668 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 5.07e-04 | 25 | 19 | 2 | M605 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 6.84e-04 | 29 | 19 | 2 | M12524 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 7.82e-04 | 31 | 19 | 2 | M39714 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 8.86e-04 | 33 | 19 | 2 | M4086 | |
| Pathway | KEGG_BUTANOATE_METABOLISM | 9.41e-04 | 34 | 19 | 2 | M3397 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 9.97e-04 | 35 | 19 | 2 | M1075 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 1.06e-03 | 36 | 19 | 2 | MM14544 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 1.30e-03 | 40 | 19 | 2 | M7934 | |
| Pathway | KEGG_TRYPTOPHAN_METABOLISM | 1.30e-03 | 40 | 19 | 2 | M980 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 1.43e-03 | 42 | 19 | 2 | M699 | |
| Pathway | KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION | 1.57e-03 | 44 | 19 | 2 | M11835 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 1.57e-03 | 44 | 19 | 2 | M13720 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.63e-03 | 177 | 19 | 3 | M27476 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.71e-03 | 681 | 19 | 5 | MM14985 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 1.87e-03 | 48 | 19 | 2 | MM15902 | |
| Pathway | KEGG_GLYCEROLIPID_METABOLISM | 1.95e-03 | 49 | 19 | 2 | M15902 | |
| Pathway | KEGG_ARGININE_AND_PROLINE_METABOLISM | 2.36e-03 | 54 | 19 | 2 | M2551 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.41e-03 | 736 | 19 | 5 | M27287 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.98e-03 | 219 | 19 | 3 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.02e-03 | 220 | 19 | 3 | M10320 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 3.10e-03 | 62 | 19 | 2 | M11521 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.31e-10 | 94 | 31 | 6 | 21542922 | |
| Pubmed | 3.41e-10 | 193 | 31 | 7 | 19343046 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 12693930 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 23454351 | ||
| Pubmed | 1.57e-09 | 18 | 31 | 4 | 18664271 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.40e-09 | 5 | 31 | 3 | 12629516 | |
| Pubmed | Maternal aldehyde elimination during pregnancy preserves the fetal genome. | 2.24e-08 | 7 | 31 | 3 | 25155611 | |
| Pubmed | ALDH1B1 is a potential stem/progenitor marker for multiple pancreas progenitor pools. | 1.05e-07 | 11 | 31 | 3 | 23142317 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 22591209 | ||
| Pubmed | Complex consequences of Cantu syndrome SUR2 variant R1154Q in genetically modified mice. | 7.69e-07 | 2 | 31 | 2 | 33529173 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 22844491 | ||
| Pubmed | Comparative genomics, molecular evolution and computational modeling of ALDH1B1 and ALDH2. | 7.69e-07 | 2 | 31 | 2 | 23247008 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 8058062 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 25047496 | ||
| Pubmed | Cloning and characterization of the gene encoding mouse mitochondrial aldehyde dehydrogenase. | 7.69e-07 | 2 | 31 | 2 | 7958964 | |
| Pubmed | Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases. | 7.69e-07 | 2 | 31 | 2 | 4015823 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 32300124 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 26181369 | ||
| Pubmed | The E3 ubiquitin ligase, HECTD1, is involved in ABCA1-mediated cholesterol export from macrophages. | 7.69e-07 | 2 | 31 | 2 | 29306077 | |
| Pubmed | ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. | 7.69e-07 | 2 | 31 | 2 | 10878804 | |
| Pubmed | Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases. | 7.69e-07 | 2 | 31 | 2 | 18450747 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 23667679 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 22384032 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 2987944 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 29189260 | ||
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 1.12e-06 | 23 | 31 | 3 | 10708515 | |
| Pubmed | 1.12e-06 | 23 | 31 | 3 | 18971422 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 18782342 | ||
| Pubmed | Functional roles of KATP channel subunits in metabolic inhibition. | 2.31e-06 | 3 | 31 | 2 | 23624089 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 17010133 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 1306115 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 17471563 | ||
| Pubmed | ABC transporters as differentiation markers in glioblastoma cells. | 2.31e-06 | 3 | 31 | 2 | 25028266 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 31138432 | ||
| Pubmed | Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. | 2.31e-06 | 3 | 31 | 2 | 23786406 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 35393951 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 8630239 | ||
| Pubmed | Aldehyde dehydrogenase is a positional marker in the retina. | 4.61e-06 | 4 | 31 | 2 | 1935685 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 11076747 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 20205700 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 7606739 | ||
| Pubmed | Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium. | 4.61e-06 | 4 | 31 | 2 | 12356945 | |
| Pubmed | Biochemical genetic analysis of human and rodent aldehyde dehydrogenase (ALDH). | 4.61e-06 | 4 | 31 | 2 | 4015840 | |
| Pubmed | Assembly limits the pharmacological complexity of ATP-sensitive potassium channels. | 4.61e-06 | 4 | 31 | 2 | 11825905 | |
| Pubmed | Expression of ATP-sensitive K+ channel subunits during perinatal maturation in the mouse heart. | 4.61e-06 | 4 | 31 | 2 | 16085792 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 10022826 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 23484127 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 28842488 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.61e-06 | 4 | 31 | 2 | 10469592 | |
| Pubmed | A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. | 4.61e-06 | 4 | 31 | 2 | 8798681 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 9819390 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 20700531 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 7.68e-06 | 5 | 31 | 2 | 11401426 | |
| Pubmed | Ankyrin-B regulates Kir6.2 membrane expression and function in heart. | 1.15e-05 | 6 | 31 | 2 | 20610380 | |
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 17628022 | ||
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 18331377 | ||
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 19805629 | ||
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 8093609 | ||
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 12128098 | ||
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 14557543 | ||
| Pubmed | Identification of the genes regulated by Wnt-4, a critical signal for commitment of the ovary. | 6.95e-05 | 14 | 31 | 2 | 25645944 | |
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 28634350 | ||
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 16109395 | ||
| Pubmed | Deletion of Stk40 impairs definitive erythropoiesis in the mouse fetal liver. | 1.92e-04 | 23 | 31 | 2 | 28358362 | |
| Pubmed | 1.92e-04 | 23 | 31 | 2 | 31850343 | ||
| Pubmed | 4.75e-04 | 36 | 31 | 2 | 38078651 | ||
| Pubmed | 6.79e-04 | 43 | 31 | 2 | 30733279 | ||
| Pubmed | New insights on the functional role of URG7 in the cellular response to ER stress. | 8.11e-04 | 47 | 31 | 2 | 29704455 | |
| Cytoband | 14q12 | 6.41e-04 | 55 | 31 | 2 | 14q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q12 | 2.31e-03 | 105 | 31 | 2 | chr14q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 3.88e-03 | 137 | 31 | 2 | chr9q31 | |
| GeneFamily | ATP binding cassette subfamily C | 4.44e-07 | 13 | 22 | 3 | 807 | |
| GeneFamily | Aldehyde dehydrogenases | 1.50e-06 | 19 | 22 | 3 | 398 | |
| GeneFamily | Fibronectin type III domain containing | 1.60e-02 | 160 | 22 | 2 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 2.28e-02 | 193 | 22 | 2 | 594 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN | 3.39e-05 | 196 | 25 | 4 | M9590 | |
| Coexpression | GSE3982_BCELL_VS_BASOPHIL_DN | 3.67e-05 | 200 | 25 | 4 | M5540 | |
| Coexpression | COLDREN_GEFITINIB_RESISTANCE_UP | 7.44e-05 | 86 | 25 | 3 | M18134 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 9.87e-05 | 503 | 25 | 5 | M2226 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL | 1.04e-04 | 16 | 25 | 2 | M2650 | |
| Coexpression | HALLMARK_PEROXISOME | 1.31e-04 | 104 | 25 | 3 | M5949 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 1.39e-04 | 541 | 25 | 5 | MM1061 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_100 | 7.19e-05 | 72 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 9.13e-05 | 78 | 24 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100 | 9.84e-05 | 80 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.14e-04 | 84 | 24 | 3 | gudmap_developingGonad_P2_testes_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 1.14e-04 | 84 | 24 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_100 | 1.18e-04 | 85 | 24 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_500 | 2.08e-04 | 103 | 24 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 2.54e-04 | 21 | 24 | 2 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.96e-04 | 116 | 24 | 3 | gudmap_developingGonad_e18.5_testes_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.35e-04 | 121 | 24 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | 4.82e-04 | 137 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#2_top-relative-expression-ranked_500 | 5.22e-04 | 30 | 24 | 2 | gudmap_developingGonad_e18.5_testes_500_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 5.46e-04 | 143 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 6.33e-04 | 33 | 24 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 6.52e-04 | 152 | 24 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 6.72e-04 | 34 | 24 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_100 | |
| CoexpressionAtlas | DE blastocyst_vs_DE bone marrow-Confounder_removed-fold2.0_adjp0.05 | 7.12e-04 | 35 | 24 | 2 | PCBC_ratio_DE blastocyst_vs_DE bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 7.29e-04 | 158 | 24 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-06 | 177 | 25 | 4 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 199 | 25 | 4 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 199 | 25 | 4 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 199 | 25 | 4 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 199 | 25 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.76e-05 | 149 | 25 | 3 | 82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.76e-05 | 149 | 25 | 3 | 14a01ae540db8a350ea26a350b2e6ce6c07639d9 | |
| ToppCell | Club-club-12|World / Class top | 1.05e-04 | 165 | 25 | 3 | 9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 1.17e-04 | 171 | 25 | 3 | 3ecd0a074344179c57eb2d9a857ba594904d00fa | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-04 | 171 | 25 | 3 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 171 | 25 | 3 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 172 | 25 | 3 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 172 | 25 | 3 | 107417cfab7775bc1f80807115047abfb50b7a7e | |
| ToppCell | (08)_PNEC-(1)_24hpi|(08)_PNEC / shred by cell type and Timepoint | 1.19e-04 | 29 | 25 | 2 | f1b59a0b6bce5772bfb084f08507cf775e7eae8c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 174 | 25 | 3 | 2fbdb62e269acf4447b171700a615e878dde7f9f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 174 | 25 | 3 | 7c52b5d8f1e65e5208c952be341fa155ed0e6e76 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 1.27e-04 | 176 | 25 | 3 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.34e-04 | 179 | 25 | 3 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-early_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 179 | 25 | 3 | 3f73f89905c061ada4e3eb921fa394d95f95c959 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 182 | 25 | 3 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac|bone_marrow / Manually curated celltypes from each tissue | 1.40e-04 | 182 | 25 | 3 | e1d6b5de5bd1d11e968da3a55e5326ef252f55ba | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 182 | 25 | 3 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.40e-04 | 182 | 25 | 3 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-04 | 184 | 25 | 3 | 0efc757d9512d6a8fe8176e977a94e4494ed9778 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.45e-04 | 184 | 25 | 3 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 185 | 25 | 3 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 186 | 25 | 3 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 186 | 25 | 3 | 6d8dd6d0403d149cb6edb346581fe6c248036785 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 186 | 25 | 3 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 186 | 25 | 3 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.52e-04 | 187 | 25 | 3 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | Club-club-14|World / Class top | 1.52e-04 | 187 | 25 | 3 | 4584de577d3736c89187e522497498e58d381c46 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 188 | 25 | 3 | 0a5b93c131ce8514e996b0c2f39e0fc98636c122 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 188 | 25 | 3 | 176a207dde6dd122a11e6c67c6299bc5179ff049 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 188 | 25 | 3 | a6cbe58c5029acefbfbb64c3bff570de4e5e2449 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 188 | 25 | 3 | 6fb37e3b139955e6ee6be26ab6cd3ce85d765ca6 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-04 | 188 | 25 | 3 | 50994e304c719f2f3c3232e48141e2dd15c96612 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-04 | 188 | 25 | 3 | a7b7ba56603a8a50869b41902aed6a9ab1c5c021 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-04 | 188 | 25 | 3 | bc0b9ba8ae88e8a89e98b446584ed39606e4229e | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 190 | 25 | 3 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 191 | 25 | 3 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 192 | 25 | 3 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 192 | 25 | 3 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 1.64e-04 | 192 | 25 | 3 | cbc304c704e8524eee24a1619d0fbb2cf96c4976 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 192 | 25 | 3 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 193 | 25 | 3 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 193 | 25 | 3 | 5578f7cb3ec68c9a38cc5304b618b81283024d5e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 193 | 25 | 3 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 193 | 25 | 3 | 50c2832de75b6469f649355c6b9a75e910d32db3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 193 | 25 | 3 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-04 | 194 | 25 | 3 | 7ad255fa357d41fe57ed803314de46a6577a1283 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 194 | 25 | 3 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 194 | 25 | 3 | b829a63b51b92507a53ffd0393bd9458b2b9440f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 194 | 25 | 3 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 194 | 25 | 3 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-04 | 195 | 25 | 3 | b67d4f34cae729c18275486d3b20c9dd7d5cbe79 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 196 | 25 | 3 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 196 | 25 | 3 | 7e19919eafd6ddf547dd4e8aa532a050e182c5cc | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 1.74e-04 | 196 | 25 | 3 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 196 | 25 | 3 | d9426eba69047166ffa8179f1654e011c1020328 | |
| ToppCell | Control|World / Condition, Lineage and Cell class | 1.74e-04 | 196 | 25 | 3 | 2565f567c5274d1689e11600a2cb9e6770b65f74 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.74e-04 | 196 | 25 | 3 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 196 | 25 | 3 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 197 | 25 | 3 | 9ae6d987e65972e1fb21aa407788d5e3ff41ad64 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 197 | 25 | 3 | c0250509836f1be04f5e54386191d7bb1e1da652 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 198 | 25 | 3 | e8bfae3888b2406b5629b576cb02913b3297337e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 198 | 25 | 3 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 199 | 25 | 3 | 9e32644b93fb1c4946dbe388fd5c357304d14e36 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.82e-04 | 199 | 25 | 3 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.82e-04 | 199 | 25 | 3 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.85e-04 | 200 | 25 | 3 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 200 | 25 | 3 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.85e-04 | 200 | 25 | 3 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 200 | 25 | 3 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.85e-04 | 200 | 25 | 3 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.85e-04 | 200 | 25 | 3 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 200 | 25 | 3 | 234e5a927eec0e235226586451ba3754c8a14169 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.85e-04 | 200 | 25 | 3 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 200 | 25 | 3 | e118d5e6e5d5bb808877a6667668c36f21afad5b | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.03e-04 | 65 | 25 | 2 | f14b28214f80ed23501ab28ff254c206f70d77b2 | |
| ToppCell | (05)_Ciliated-(0)_uninjured|(05)_Ciliated / shred by cell type and Timepoint | 1.53e-03 | 104 | 25 | 2 | 0039ceeb70bec569b2d5e18be68f6c97973b80f5 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.65e-03 | 108 | 25 | 2 | ba83418023d9d296b0edd4c4e1832a33bc9b3b69 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Deptor_(Deep_layer_pyramidal_cells--Layer_5a)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.65e-03 | 108 | 25 | 2 | 514dfc3f7ac303311ae599f981f3f3c7eb6801b8 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.65e-03 | 108 | 25 | 2 | a93a427ab16628c86db3bb17bfecf801f56ce270 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.65e-03 | 108 | 25 | 2 | 673da75b24218557d01ee461a13c426040da74b9 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-03 | 115 | 25 | 2 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 1.87e-03 | 115 | 25 | 2 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-03 | 115 | 25 | 2 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-03 | 115 | 25 | 2 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-03 | 117 | 25 | 2 | c6fc72608d56a389bcd87b5dc98a11e39b79bcb2 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 118 | 25 | 2 | 3cebd17f4688cd43fe1283dc60957e87d5536810 | |
| Computational | CoA and fatty acid metabolism. | 4.46e-06 | 19 | 19 | 3 | MODULE_305 | |
| Computational | Genes in the cancer module 184. | 1.66e-05 | 29 | 19 | 3 | MODULE_184 | |
| Computational | Fatty acid metabolism. | 1.84e-05 | 30 | 19 | 3 | MODULE_221 | |
| Computational | Genes in the cancer module 333. | 1.17e-03 | 29 | 19 | 2 | MODULE_333 | |
| Drug | indole-3-acetaldehyde | 1.91e-08 | 28 | 24 | 4 | CID000000800 | |
| Drug | Glyburide | 5.74e-08 | 8 | 24 | 3 | DB01016 | |
| Drug | L 574 | 8.61e-08 | 9 | 24 | 3 | CID000067114 | |
| Drug | Malondialdehyde | 1.14e-07 | 43 | 24 | 4 | ctd:D008315 | |
| Drug | NSC85552 | 1.23e-07 | 10 | 24 | 3 | CID003000646 | |
| Drug | ampal | 1.69e-07 | 11 | 24 | 3 | CID000129385 | |
| Drug | phenylketophosphamide | 2.25e-07 | 12 | 24 | 3 | CID000127726 | |
| Drug | carboxyphosphamide | 5.71e-07 | 16 | 24 | 3 | CID000031515 | |
| Drug | 4-dimethylaminocinnamaldehyde | 1.06e-06 | 2 | 24 | 2 | ctd:C018523 | |
| Drug | DEAB | 1.80e-06 | 23 | 24 | 3 | CID000056566 | |
| Drug | aldophosphamide | 2.05e-06 | 24 | 24 | 3 | CID000107744 | |
| Drug | Benzaldehydes | 3.19e-06 | 3 | 24 | 2 | ctd:D001547 | |
| Drug | phosphoramide mustard | 4.10e-06 | 30 | 24 | 3 | CID000096356 | |
| Drug | decanal | 4.54e-06 | 31 | 24 | 3 | CID000008175 | |
| Drug | betaine aldehyde | 5.00e-06 | 32 | 24 | 3 | CID000000249 | |
| Drug | Adenosine triphosphate | 5.50e-06 | 33 | 24 | 3 | DB00171 | |
| Drug | daidzin | 5.50e-06 | 33 | 24 | 3 | CID000107971 | |
| Drug | furfural | 7.18e-06 | 36 | 24 | 3 | CID000007362 | |
| Drug | octanal | 7.81e-06 | 37 | 24 | 3 | CID000000454 | |
| Drug | 4-hydroxycyclophosphamide | 8.47e-06 | 38 | 24 | 3 | CID000099735 | |
| Drug | DETC-MeSO | 9.17e-06 | 39 | 24 | 3 | CID003035711 | |
| Drug | Ethoxyquin | 9.91e-06 | 40 | 24 | 3 | ctd:D005015 | |
| Drug | thioformamide | 1.06e-05 | 5 | 24 | 2 | CID003005587 | |
| Drug | n-butoxyacetaldehyde | 1.06e-05 | 5 | 24 | 2 | ctd:C053320 | |
| Drug | 1 sulfonylurea | 1.44e-05 | 143 | 24 | 4 | CID011819083 | |
| Drug | 2-methoxyacetaldehyde | 1.59e-05 | 6 | 24 | 2 | ctd:C049826 | |
| Drug | 4-(N,N-dipropylamino)benzaldehyde | 1.59e-05 | 6 | 24 | 2 | CID000069171 | |
| Drug | hexanal | 1.62e-05 | 47 | 24 | 3 | CID000006184 | |
| Drug | p-nitrobenzaldehyde | 1.73e-05 | 48 | 24 | 3 | CID000000541 | |
| Drug | chlorpropamide | 1.73e-05 | 48 | 24 | 3 | CID000002727 | |
| Drug | diethyl maleate | 1.76e-05 | 318 | 24 | 5 | ctd:C014476 | |
| Drug | mepyramine | 1.92e-05 | 154 | 24 | 4 | CID000004992 | |
| Drug | ASTA Z 7557 | 1.95e-05 | 50 | 24 | 3 | CID000335628 | |
| Drug | propionaldehyde | 2.07e-05 | 51 | 24 | 3 | CID000000527 | |
| Drug | N1-ethylchlorpropamide | 2.23e-05 | 7 | 24 | 2 | CID000362592 | |
| Drug | PNP dimethylcarbamate | 2.23e-05 | 7 | 24 | 2 | CID000081656 | |
| Drug | 3-butynoate | 2.23e-05 | 7 | 24 | 2 | CID000137547 | |
| Drug | 3-butynal | 2.23e-05 | 7 | 24 | 2 | CID000142966 | |
| Drug | glutamic gamma-semialdehyde | 2.33e-05 | 53 | 24 | 3 | CID000000844 | |
| Drug | Glutathione | 2.43e-05 | 340 | 24 | 5 | ctd:D005978 | |
| Drug | chloroacetaldehyde | 2.60e-05 | 55 | 24 | 3 | CID000000033 | |
| Drug | AC1L8X1L | 2.97e-05 | 8 | 24 | 2 | CID000409504 | |
| Drug | C04554 | 2.97e-05 | 8 | 24 | 2 | CID000440384 | |
| Drug | ethylphenyl(2-formylethyl)phosphinate | 2.97e-05 | 8 | 24 | 2 | CID000151185 | |
| Drug | benzaldehyde | 2.97e-05 | 8 | 24 | 2 | ctd:C032175 | |
| Drug | nitrefazole | 2.97e-05 | 8 | 24 | 2 | CID000071900 | |
| Drug | benzaldehyde | 3.39e-05 | 60 | 24 | 3 | CID000000240 | |
| Drug | CPD 30 | 3.82e-05 | 9 | 24 | 2 | CID000440850 | |
| Drug | 6-methoxy-2-naphthaldehyde | 3.82e-05 | 9 | 24 | 2 | CID000076991 | |
| Drug | 4-acetamidobutyrate | 3.82e-05 | 9 | 24 | 2 | CID000018189 | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.03e-05 | 186 | 24 | 4 | 5777_DN | |
| Drug | glibenclamide | 4.23e-05 | 382 | 24 | 5 | CID000003488 | |
| Drug | Me-DTC | 4.77e-05 | 10 | 24 | 2 | CID000012704 | |
| Drug | vernolate | 4.77e-05 | 10 | 24 | 2 | CID000016003 | |
| Drug | glycolaldehyde | 4.77e-05 | 10 | 24 | 2 | ctd:C010972 | |
| Drug | resorufin acetate | 4.77e-05 | 10 | 24 | 2 | CID003080579 | |
| Drug | succinic semialdehyde | 5.15e-05 | 69 | 24 | 3 | CID000001112 | |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | 5.25e-05 | 199 | 24 | 4 | 6882_DN | |
| Drug | Magnesium | 5.61e-05 | 71 | 24 | 3 | ctd:D008274 | |
| Drug | 2-phenylpropanal | 5.82e-05 | 11 | 24 | 2 | CID000007146 | |
| Drug | 4-nitrophenyl acetate | 5.82e-05 | 11 | 24 | 2 | ctd:C008642 | |
| Drug | ynoate | 5.82e-05 | 11 | 24 | 2 | CID000010110 | |
| Drug | 4-HC | 5.85e-05 | 72 | 24 | 3 | CID000038347 | |
| Drug | perfosfamide | 6.35e-05 | 74 | 24 | 3 | ctd:C011272 | |
| Drug | imidazole acetaldehyde | 6.98e-05 | 12 | 24 | 2 | CID000150841 | |
| Drug | NAD | 8.02e-05 | 80 | 24 | 3 | ctd:D009243 | |
| Drug | octadecanal | 8.25e-05 | 13 | 24 | 2 | CID000012533 | |
| Drug | p-nitrophenyl acetate | 8.95e-05 | 83 | 24 | 3 | CID000013243 | |
| Drug | 4-methylpyrazole | 9.27e-05 | 84 | 24 | 3 | CID000003406 | |
| Drug | 4-(diethylamino)benzaldehyde | 9.62e-05 | 14 | 24 | 2 | ctd:C055506 | |
| Drug | Span 40 | 9.62e-05 | 14 | 24 | 2 | CID000014927 | |
| Drug | 1-aminocyclopropanol | 9.62e-05 | 14 | 24 | 2 | CID000148676 | |
| Drug | C11102 | 9.94e-05 | 86 | 24 | 3 | CID000443069 | |
| Drug | Streptozocin | 1.06e-04 | 756 | 24 | 6 | ctd:D013311 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 1.11e-04 | 15 | 24 | 2 | CID000440673 | |
| Drug | tert-butyl formate | 1.11e-04 | 15 | 24 | 2 | CID000061207 | |
| Drug | amprolium | 1.27e-04 | 16 | 24 | 2 | CID000002178 | |
| Drug | glycurone | 1.27e-04 | 16 | 24 | 2 | CID000003483 | |
| Drug | heptanal | 1.27e-04 | 16 | 24 | 2 | CID000008130 | |
| Drug | NN414 | 1.27e-04 | 16 | 24 | 2 | CID000219048 | |
| Drug | alinidine | 1.43e-04 | 17 | 24 | 2 | CID000036354 | |
| Drug | trimethylaminobutyraldehyde | 1.43e-04 | 17 | 24 | 2 | CID000000133 | |
| Drug | propynal | 1.43e-04 | 17 | 24 | 2 | CID000012222 | |
| Drug | phenylacetaldehyde | 1.56e-04 | 100 | 24 | 3 | CID000000998 | |
| Drug | isovanillin | 1.61e-04 | 18 | 24 | 2 | CID000012127 | |
| Drug | beta-alanine | 1.75e-04 | 104 | 24 | 3 | CID000000239 | |
| Drug | SMDM | 1.80e-04 | 19 | 24 | 2 | CID000119467 | |
| Drug | 5-HIAL | 1.80e-04 | 19 | 24 | 2 | CID000074688 | |
| Drug | DOPAC | 2.18e-04 | 112 | 24 | 3 | CID000000547 | |
| Drug | cyanoguanidine | 2.21e-04 | 21 | 24 | 2 | CID000010005 | |
| Drug | Glyoxal | 2.21e-04 | 21 | 24 | 2 | ctd:D006037 | |
| Drug | 2,4-decadienal | 2.21e-04 | 21 | 24 | 2 | ctd:C057349 | |
| Drug | perillaldehyde | 2.21e-04 | 21 | 24 | 2 | CID000016441 | |
| Drug | coprine | 2.43e-04 | 22 | 24 | 2 | CID000108079 | |
| Drug | Butylated Hydroxyanisole | 2.54e-04 | 118 | 24 | 3 | ctd:D002083 | |
| Drug | dicyclanil | 2.94e-04 | 124 | 24 | 3 | ctd:C121718 | |
| Drug | 2-cyano-3-phenylacrylic acid | 3.15e-04 | 25 | 24 | 2 | CID000070534 | |
| Drug | gamma-aminobutyraldehyde | 3.15e-04 | 25 | 24 | 2 | CID000000118 | |
| Drug | NCS 382 | 3.15e-04 | 25 | 24 | 2 | ctd:C066471 | |
| Drug | 5-HIAA | 3.30e-04 | 129 | 24 | 3 | CID000001826 | |
| Disease | Colorectal Neoplasms | 9.88e-08 | 277 | 25 | 6 | C0009404 | |
| Disease | Colorectal Carcinoma | 1.39e-06 | 702 | 25 | 7 | C0009402 | |
| Disease | gout | 2.14e-05 | 196 | 25 | 4 | EFO_0004274 | |
| Disease | Alcohol abuse | 2.48e-05 | 67 | 25 | 3 | C0085762 | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.83e-05 | 70 | 25 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 2.83e-05 | 70 | 25 | 3 | C3241937 | |
| Disease | obesity (implicated_via_orthology) | 3.07e-05 | 215 | 25 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | alcohol drinking | 4.39e-05 | 81 | 25 | 3 | EFO_0004329 | |
| Disease | Liver Failure, Acute | 1.88e-04 | 24 | 25 | 2 | C0162557 | |
| Disease | Malignant neoplasm of liver | 2.32e-04 | 142 | 25 | 3 | C0345904 | |
| Disease | Liver neoplasms | 2.32e-04 | 142 | 25 | 3 | C0023903 | |
| Disease | right ventricular ejection fraction measurement | 2.95e-04 | 30 | 25 | 2 | EFO_0021816 | |
| Disease | Alcoholic Intoxication | 3.37e-04 | 32 | 25 | 2 | C0001969 | |
| Disease | Parkinsonism (biomarker_via_orthology) | 3.80e-04 | 34 | 25 | 2 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 4.00e-04 | 171 | 25 | 3 | DOID:9352 (is_implicated_in) | |
| Disease | Liver Cirrhosis, Experimental | 4.21e-04 | 774 | 25 | 5 | C0023893 | |
| Disease | coffee consumption measurement | 4.80e-04 | 182 | 25 | 3 | EFO_0006781 | |
| Disease | Alcohol Use Disorder | 6.38e-04 | 44 | 25 | 2 | C0001956 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAPGCLMPAVQNWLV | 56 | O42043 | |
| RAPGCLMPAVQNWLV | 166 | Q9UKH3 | |
| GVFMPIGIVLQPWMG | 1341 | P35670 | |
| VGVCGQIIPWNFPLV | 176 | P30837 | |
| MPSAGTLPWVQGIIC | 61 | O95477 | |
| GVCGQIIPWNFPLVM | 161 | P00352 | |
| CPNLWAMPVQIIMGV | 431 | O60706 | |
| IGYINTPGPVCQLMW | 611 | Q96MT7 | |
| TQPVLPGFMVWCGGL | 481 | Q9BXM9 | |
| MTPVKGEPLGVICNW | 321 | Q9P265 | |
| ACVSPGENQLPVWMP | 836 | P63132 | |
| FKWMIFNGGAPNCIP | 76 | P19883 | |
| MIAGVFPWFLVAVGP | 1006 | O15440 | |
| VAILQSPGDWMCPVN | 476 | Q9ULT8 | |
| VPMGQNVTLWCRGPV | 981 | Q8N6C5 | |
| TAPGCLMPAVQNWLV | 56 | P61566 | |
| RAPGCLMPAVQNWLV | 56 | P61567 | |
| RAPGCLMPAVQNWLV | 166 | P61565 | |
| RAPGCLMPAVQNWLV | 56 | Q9HDB8 | |
| NFCLPGVPWNMTVIT | 146 | Q53GD3 | |
| MPIMIGGFGNWLVPL | 71 | P00395 | |
| WLMGVFEPNNPVCFL | 881 | P51530 | |
| IGCQAMGVPLPTLQW | 406 | Q7Z5N4 | |
| MLLIVWLPFCGPNVI | 181 | Q8NGB2 | |
| PWMSAPIQVGLVGFC | 261 | Q9H9B4 | |
| AMVQAWPFTCLPLGV | 71 | P78395 | |
| WPFTCLPLGVLMKGQ | 76 | P78395 | |
| VQCLAWVPSAPGMFI | 271 | Q8IZU2 | |
| IQFISPGQPWEEVMC | 441 | Q13017 | |
| VMPGRTLCFVQWPEG | 226 | P29371 | |
| PNLWAMPVQIIVGVI | 436 | Q09428 | |
| WVLGIFQIGPVAGVM | 811 | Q14246 | |
| VGVCGQIIPWNFPLL | 176 | P05091 | |
| DWCGLIPVGQPCMQV | 181 | Q9H3S4 |